APRIL 22-28, 2022
The global market for nuclear medicine is expected to quintuple in about a decade, and a large slice of that growth is expected to occur in the Indianapolis area. John Russell reports that Telix Pharmaceuticals, which has developed an imaging agent that makes cancer cells light up in scans, is having a breakout moment. Also in this week’s issue, Susan Orr unravels the story of a Fishers man facing a tangle of legal issues related to accusations he was involved in the nationwide sale of more than $230 million in questionable financial products. And Daniel Bradley reports that interest is accelerating in the slow-to-develop Zionsville’s Creekside Corporate Park now that construction of the new Rahal Letterman Lanigan Racing team headquarters is well under way.